Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
There is a clear and pressing need to expand pharmacotherapy options for substance use disorders (SUDs) in order to improve sustained abstinence outcomes. Preclinical literature has demonstrated the role of glutamate in addiction, suggesting that new targets for pharmacotherapy should focus on the restoration of glutamatergic function. Glutamatergic agents for SUDs may span multiple addictive behaviors and help demonstrate potentially overlapping mechanisms in addiction. The current review will focus specifically on N-acetylcysteine (NAC), a safe and well-tolerated glutamatergic agent, as a promising potential pharmacotherapy for the treatment of SUDs across several substances of abuse. Building on recently published reviews of the clinical efficacy of NAC across a broad range of conditions, this review will more specifically discuss NAC as a pharmacotherapy for SUDs, devoting particular attention to the safety and tolerability profile of NAC, the wealth of preclinical evidence that has demonstrated the role of glutamate dysregulation in addiction, and the limited but growing clinical literature that has assessed the efficacy of NAC across multiple substances of abuse. Preliminary clinical studies show the promise of NAC in terms of safety, tolerability, and potential efficacy for promoting abstinence from cocaine, nicotine, and cannabis. Results from randomized clinical trials have been mixed, but several mechanistic and methodological factors are discussed to refine the use of NAC in promoting abstinence and relapse prevention across several substances of abuse. Further preclinical and clinical investigation into the use of NAC for SUDs will be vital in addressing current deficits in the treatment of SUDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870 · cited 1×
“tobacco and alcohol) substances in the US (illicit drugs and tobacco) and globally (alcohol) [1–3].”
BackgroundBowman, P. W. (1963) · AIBS Bulletin · doi:10.2307/1292957 · Cited by 3,638
Treating Tobacco Use and Dependence: 2008 Update: (566222009-001)
(2009) · PsycEXTRA Dataset · doi:10.1037/e566222009-001 · Cited by 3,046 · cited 1×
“Replacement pharmacotherapy has also been a key strategy in treatment guidelines for nicotine dependence [9].”
BackgroundTreating Tobacco Use and Dependence
(2008) · Pediatrics · doi:10.1542/peds.2008-1627 · Cited by 2,697
Structural basis of long-term potentiation in single dendritic spines
Matsuzaki, M., Honkura, N., Ellis-Davies, G. C. R., & Kasai, H. (2004) · Nature · doi:10.1038/nature02617 · Cited by 2,483 · cited 1×
“Since presynaptic and non-synaptic glutamate release regulates synaptic plasticity in both primary cell cultures and in vivo [63, 64], the LTP-like changes may arise from the reinstatement-associated increase in glutamate release and overflow [44, 45, 65].”
BackgroundThe role of the basal ganglia in habit formation
Yin, H. H., & Knowlton, B. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1919 · Cited by 2,402 · cited 1×
“Within the corticostriatal circuit, the NAcore is thought to serve as a ‘gateway’ through which information concerning behavioral output is processed from the limbic cortex to motor subcircuits [67, 68].”
BackgroundClinical Practice Guideline: Otitis Media with Effusion (Update)
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006
Jorenby, D. E. (2006) · JAMA · doi:10.1001/jama.296.1.56 · Cited by 1,635 · cited 2×
“However, even with varenicline, arguably the most efficacious smoking cessation pharmacotherapy, abstinence rates after 12 weeks of treatment are still only approximately 40 % [12–14].”
BackgroundTanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Gonzales, D. (2006) · JAMA · doi:10.1001/jama.296.1.47 · Cited by 1,361 · cited 2×
“However, even with varenicline, arguably the most efficacious smoking cessation pharmacotherapy, abstinence rates after 12 weeks of treatment are still only approximately 40 % [12–14].”
BackgroundThe glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · cited 1×
“recreational use) arises from an impaired ability of this circuit to successfully process negative environmental contingencies, leading to decreased capacity to inhibit prepotent drugassociated responses [41, 69].”
BackgroundSelf-citationPharmacological interventions for smoking cessation: an overview and network meta-analysis
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009329.pub2 · Cited by 1,243 · cited 1×
“Within the smoking cessation literature, nicotine replacement therapy (NRT), bupropion, and varenicline have been shown to increase the odds of quitting smoking by two to threefold compared with placebo [11].”
BackgroundDole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240 · cited 1×
“methadone maintenance) were demonstrated to be effective in improving treatment outcomes [7], thus representing a pivotal moment in the treatment of SUDs.”
BackgroundEfficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102 · cited 1×
“It is also used as an oral or intravenous antidote to treat acetaminophen poisoning, acting as a precursor for the synthesis of the antioxidant glutathione (GSH), and forming complexes with toxic reactive oxidative metabolites of acetaminophen, ultimately preventing hepatic cell necrosis [29].”
BackgroundOxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · cited 2×
“Based on evidence supporting the role of oxidative stress as a mechanism underlying psychiatric disorders [36], it will be important to study this specifically for the treatment of SUDs.”
BackgroundLewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978 · cited 6×
“GSH is depleted during oxidative stress, which can be reversed with NAC treatment [37], and providing evidence to pursue GSH as a novel therapeutic target for psychiatric disorders [38].”
BackgroundInfluentialSelf-citationMcFarland, K., Lapish, C. C., & Kalivas, P. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03531.2003 · Cited by 885 · cited 1×
“nicotine, dysregulation of glutamatergic signaling has been found within a corticostriatal circuit [prefrontal cortex (PFC)–nucleus accumbens (NA)] [41, 44–46].”
BackgroundSelf-citationVital signs: current cigarette smoking among adults aged >or=18 years --- United States, 2009.
Peachacek, T. F., Kaufmann, R. B., Caraballo, R. S., James, C., Regan, A. K., & Dube, S. R. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 852
Oxidative Stress in Chronic Obstructive Pulmonary Disease
REPINE, J. E., BAST, A., LANKHORST, I., & The Oxidative Stress Study Group (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.2.9611013 · Cited by 843 · cited 1×
“NAC has clinical efficacy as a mucolytic agent for bronchopulmonary disorders [27] and in the treatment of chronic obstructive pulmonary disease (COPD) [28].”
BackgroundFormation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving
Conrad, K. L., Tseng, K. Y., Uejima, J. L., Reimers, J. M., Heng, L.-J., Shaham, Y., Marinelli, M., & Wolf, M. E. (2008) · Nature · doi:10.1038/nature06995 · Cited by 790 · cited 1×
“The reduction in activation of GluN2B NMDA receptors could influence insertion of calcium-permeable AMPA subunit receptors (GluA1), which are increased during incubation of cocaine craving [79].”
BackgroundOpioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
Papouin, T., Ladépêche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., Groc, L., Pollegioni, L., Mothet, J.-P., & Oliet, S. H. R. (2012) · Cell · doi:10.1016/j.cell.2012.06.029 · Cited by 754 · cited 2×
“It is possible that restoration of GLT1 after treatment with NAC will inhibit glutamate spillover into the extrasynaptic space via increased glutamate uptake [77], thus inhibiting activation of the primarily extrasynaptic NMDA receptor subunit, GluN2B [78].”
BackgroundNeuroadaptations in cystine-glutamate exchange underlie cocaine relapse
Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X.-C., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 739 · cited 12×
“Extensive evidence indicates that chronic exposure to addictive drugs decreases the expression of the excitatory amino-acid transporter-2 (EAAT2), also known as glial glutamate transporter-1 (GLT1), in the NA [44, 47–49].”
BackgroundInfluentialSelf-citationN-Acetylcysteine—a safe antidote for cysteine/glutathione deficiency
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., & Herzenberg, L. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.04.005 · Cited by 721 · cited 1×
“GSH is depleted during oxidative stress, which can be reversed with NAC treatment [37], and providing evidence to pursue GSH as a novel therapeutic target for psychiatric disorders [38].”
BackgroundUnmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission
Kalivas, P. W., Volkow, N., & Seamans, J. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.005 · Cited by 657
Self-citationPierce, R., Bell, K., Duffy, P., & Kalivas, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01550.1996 · Cited by 623 · cited 1×
“This decrease in turn reduces glutamate elimination from the extracellular space and contributes to the spillover of synaptically released glutamate during reinstated drug seeking [50–52].”
BackgroundSelf-citationInfralimbic Prefrontal Cortex Is Responsible for Inhibiting Cocaine Seeking in Extinguished Rats
Peters, J., LaLumiere, R. T., & Kalivas, P. W. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1045-08.2008 · Cited by 537 · cited 1×
“Specifically, input to the shell subcompartment of the NA from the infralimbic cortex [70], and similar neurobiological alterations, have been found in the NA shell as”
BackgroundSelf-citationVital Signs: Current Cigarette Smoking Among Adults Aged ≥18Years — United States, 2009
Tanoue, L. T. (2011) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2011.01.006 · Cited by 501
Glutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484 · cited 1×
“as a ubiquitous finding and underlying feature across SUDs [20, 21, 98].”
BackgroundVital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010.
(2011) · PubMed · Cited by 443
The promise of N-acetylcysteine in neuropsychiatry
Berk, M., Malhi, G. S., Gray, L. J., & Dean, O. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.001 · Cited by 434
N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility
Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004332.pub2 · Cited by 412
N-Acetylcysteine reverses cocaine-induced metaplasticity
Moussawi, K., Pacchioni, A., Moran, M., Olive, M. F., Gass, J. T., Lavin, A., & Kalivas, P. W. (2009) · Nature Neuroscience · doi:10.1038/nn.2250 · Cited by 399 · cited 1×
“protection [63, 84].”
Self-citationThe neurobiology of addiction: a neuroadaptational view relevant for diagnosis
Koob, G. F. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01586.x · Cited by 397 · cited 1×
“recreational use) arises from an impaired ability of this circuit to successfully process negative environmental contingencies, leading to decreased capacity to inhibit prepotent drugassociated responses [41, 69].”
BackgroundCeftriaxone Restores Glutamate Homeostasis and Prevents Relapse to Cocaine Seeking
Knackstedt, L. A., Melendez, R. I., & Kalivas, P. W. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.018 · Cited by 397 · cited 1×
“Following withdrawal from cocaine and nicotine, the xCT subunit of the Xc- system is reduced both in function and content [47, 48].”
MethodSelf-citationGlutamate transmission in addiction
Kalivas, P. W., LaLumiere, R. T., Knackstedt, L., & Shen, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.011 · Cited by 388 · cited 2×
“as a ubiquitous finding and underlying feature across SUDs [20, 21, 98].”
BackgroundSelf-citationOncken, C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1571 · Cited by 380
Glutamate Release in the Nucleus Accumbens Core Is Necessary for Heroin Seeking
LaLumiere, R. T., & Kalivas, P. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5129-07.2008 · Cited by 368 · cited 2×
“with elevated extracellular glutamate derived from synaptic activity in the PFC-NA pathway [44, 45, 59].”
BackgroundSelf-citationPharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine
Olsson, B., Johansson, M., Gabrielsson, J., & Bolme, P. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf01061422 · Cited by 351 · cited 1×
“A notable limitation to the use of NAC for SUDs is its poor oral bioavailability, which is approximately 4–10 % [25, 26].”
BackgroundSpine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350 · cited 1×
“The LTP-like changes observed in these studies were quantified as increases in dendritic spine head diameter (dh) and in the ratio of a-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid (AMPA) receptor to NMDA-mediated excitatory postsynaptic currents (EPSCs; AMPA/NMDA) [60–62].”
MethodNew medications for drug addiction hiding in glutamatergic neuroplasticity
Kalivas, P. W., & Volkow, N. D. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.46 · Cited by 349 · cited 2×
“as a ubiquitous finding and underlying feature across SUDs [20, 21, 98].”
BackgroundSelf-citationChapter 29 The nucleus accumbens: gateway for limbic structures to reach the motor system?
Groenewegen, H. J., Wright, C. I., & Beijer, A. V. J. (1996) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61883-x · Cited by 344
Pharmacokinetics of N-acetylcysteine in man
Borgstr�m, L., K�gedal, B., & Paulsen, O. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606662 · Cited by 342
A Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents
Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306 · cited 4×
“Gray and colleagues [95] conducted an 8-week, placebo-controlled RCT with cannabis-dependent adolescents (N = 116; aged 15–21 years) and tested the efficacy of NAC (2,400 mg/day; 1,200 mg twice daily) versus placebo, added to contingency management and”
BackgroundMethodInfluentialSelf-citationCaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking
Anderson, S. M., Famous, K. R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H. D., Bass, C. E., Terwilliger, E. F., Cha, J.-H. J., & Pierce, R. C. (2008) · Nature Neuroscience · doi:10.1038/nn2054 · Cited by 295 · cited 1×
“well as the core [47, 71].”
Grandjean, E. M., Berthet, P., Ruffmann, R., & Leuenberger, P. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88479-9 · Cited by 270 · cited 3×
“NAC has clinical efficacy as a mucolytic agent for bronchopulmonary disorders [27] and in the treatment of chronic obstructive pulmonary disease (COPD) [28].”
BackgroundThe Role of Cystine-Glutamate Exchange in Nicotine Dependence in Rats and Humans
Knackstedt, L. A., LaRowe, S., Mardikian, P., Malcolm, R., Upadhyaya, H., Hedden, S., Markou, A., & Kalivas, P. W. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.040 · Cited by 260 · cited 3×
“Following withdrawal from cocaine and nicotine, the xCT subunit of the Xc- system is reduced both in function and content [47, 48].”
BackgroundMethodSelf-citationOpioid antagonists for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Vecchi, S., Srisurapanont, M., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867.pub3 · Cited by 247 · cited 1×
“acamprosate [15, 16].”
Reinstatement of nicotine seeking is mediated by glutamatergic plasticity
Gipson, C. D., Reissner, K. J., Kupchik, Y. M., Smith, A. C. W., Stankeviciute, N., Hensley-Simon, M. E., & Kalivas, P. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220591110 · Cited by 246 · cited 12×
“Accordingly, the LTP-like plasticity was prevented by inhibiting PFC glutamatergic input to the NAcore [66].”
BackgroundInfluentialSelf-citationZhou, W., & Kalivas, P. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.008 · Cited by 225 · cited 2×
“In animals being withdrawn from chronic heroin administration, chronic NAC administration was shown to decrease extinction responding and inhibit cue-induced heroin seeking up to 40 days after discontinuing NAC treatment [82].”
BackgroundSelf-citationRepeated N-Acetylcysteine Administration Alters Plasticity-Dependent Effects of Cocaine
Madayag, A., Lobner, D., Kau, K. S., Mantsch, J. R., Abdulhameed, O., Hearing, M., Grier, M. D., & Baker, D. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2808-07.2007 · Cited by 225 · cited 1×
“In support of this, daily NAC treatment given prior to cocaine self-administration sessions has been shown to prevent escalation of cocaine intake, behavioral sensitization, and cocaine-induced reinstatement of cocaine seeking [85].”
BackgroundLTP Promotes a Selective Long-Term Stabilization and Clustering of Dendritic Spines
De Roo, M., Klauser, P., & Muller, D. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060219 · Cited by 223
Relapse Induced by Cues Predicting Cocaine Depends on Rapid, Transient Synaptic Potentiation
Gipson, C. D., Kupchik, Y. M., Shen, H., Reissner, K. J., Thomas, C. A., & Kalivas, P. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.005 · Cited by 220 · cited 9×
“Accordingly, the LTP-like plasticity was prevented by inhibiting PFC glutamatergic input to the NAcore [66].”
BackgroundInfluentialSelf-citationGlutamatergic medications for the treatment of drug and behavioral addictions
Olive, M. F., Cleva, R. M., Kalivas, P. W., & Malcolm, R. J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.015 · Cited by 210 · cited 1×
“Specific to the treatment of SUDs, there is increasing evidence to support the role of glutamatergic signaling in addiction [20, 21, 41–43], which will be discussed in greater detail in this review.”
BackgroundSelf-citationIs Cocaine Desire Reduced by N -Acetylcysteine?
LaRowe, S. D., Myrick, H., Hedden, S., Mardikian, P., Saladin, M., McRae, A., Brady, K., Kalivas, P. W., & Malcolm, R. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1115 · Cited by 210 · cited 1×
“As part of the same inpatient trial that assessed the safety and tolerability of NAC [88], another study was published that assessed the effects of NAC on cue-induced cocaine craving [91].”
BackgroundSelf-citationGlutamatergic targets for new alcohol medications
Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3226-2 · Cited by 197
Knackstedt, L. A., Moussawi, K., Lalumiere, R., Schwendt, M., Klugmann, M., & Kalivas, P. W. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1244-10.2010 · Cited by 197 · cited 1×
“However, in the absence of this inhibitory tone, excessive glutamatergic transmission occurs [53].”
BackgroundSelf-citationAdverse reactions to acetylcysteine and effects of overdose.
Mant, T. G., Tempowski, J. H., Volans, G. N., & Talbot, J. C. (1984) · BMJ · doi:10.1136/bmj.289.6439.217 · Cited by 194 · cited 1×
“Systemic allergic reactions to NAC have been observed, but only with intravenous administration [31, 32], and seizures have been reported at very high intravenous doses [33].”
BackgroundGlutathione: a novel treatment target in psychiatry
Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.001 · Cited by 183 · cited 1×
“GSH is depleted during oxidative stress, which can be reversed with NAC treatment [37], and providing evidence to pursue GSH as a novel therapeutic target for psychiatric disorders [38].”
BackgroundSafety and Tolerability of N‐Acetylcysteine in Cocaine‐Dependent Individuals
LaRowe, S. D., Mardikian, P., Malcolm, R., Myrick, H., Kalivas, P., McFarland, K., Saladin, M., McRae, A., & Brady, K. (2006) · The American Journal on Addictions · doi:10.1080/10550490500419169 · Cited by 180 · cited 2×
“As part of the same inpatient trial that assessed the safety and tolerability of NAC [88], another study was published that assessed the effects of NAC on cue-induced cocaine craving [91].”
BackgroundMethodSelf-citationAn open-label trial of N-acetylcysteine for the treatment of cocaine dependence: A pilot study
Mardikian, P. N., LaRowe, S. D., Hedden, S., Kalivas, P. W., & Malcolm, R. J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.10.001 · Cited by 179 · cited 1×
“Recommended doses of 1,200 or 2,400 mg are often given across two to four pills taken two to three times per day, and some studies suggest that higher doses may be preferable for treatment outcomes [89].”
BackgroundSelf-citationReversing cocaine-induced synaptic potentiation provides enduring protection from relapse
Moussawi, K., Zhou, W., Shen, H., Reichel, C. M., See, R. E., Carr, D. B., & Kalivas, P. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011265108 · Cited by 175 · cited 2×
“Although not yet shown, it would also be of interest to examine the effect of NAC on reducing the basal potentiated resting state of NAcore medium spiny neurons (MSNs) after withdrawal from chronic drug self-administration [63].”
BackgroundSelf-citationA double‐blind placebo‐controlled trial of N‐acetylcysteine in the treatment of cocaine dependence
LaRowe, S. D., Kalivas, P. W., Nicholas, J. S., Randall, P. K., Mardikian, P. N., & Malcolm, R. J. (2013) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12034.x · Cited by 164
Self-citationThe Economic Impact of Illicit Drug Use on American Society: (618422012-001)
(2011) · PsycEXTRA Dataset · doi:10.1037/e618422012-001 · Cited by 162
N‐Acetyl Cysteine‐Induced Blockade of Cocaine‐Induced Reinstatement
Baker, D. L., McFarland, K., LAKE, R. W., Shen, H., Toda, S., & Kalivas, P. W. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.023 · Cited by 148 · cited 1×
“This decrease in turn reduces glutamate elimination from the extracellular space and contributes to the spillover of synaptically released glutamate during reinstated drug seeking [50–52].”
BackgroundSelf-citationSchmaal, L., Veltman, D. J., Nederveen, A., van den Brink, W., & Goudriaan, A. E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.66 · Cited by 148 · cited 2×
“Schmaal and colleagues [75] recruited cocaine-dependent adult males (N = 10) and healthy controls (N = 14) to assess glutamate activity in the dorsal anterior cingulate cortex (dACC) using proton magnetic resonance spectroscopy.”
BackgroundMethodEvidence-Based Treatment of Opioid-Dependent Patients
van den Brink, W., & Haasen, C. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101003 · Cited by 147
Rapid, transient synaptic plasticity in addiction
Gipson, C. D., Kupchik, Y. M., & Kalivas, P. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.032 · Cited by 146 · cited 1×
“The reduction in GluA1-containing AMPA receptors could inhibit the rapid increase in dh shown to be linked to increased relapse vulnerability [55, 56].”
BackgroundSelf-citationAmen, S. L., Piacentine, L. B., Ahmad, M. E., Li, S.-J., Mantsch, J. R., Risinger, R. C., & Baker, D. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.226 · Cited by 140 · cited 2×
“A translational study was conducted that utilized preclinical and clinical designs to assess the influence of repeated administration of NAC on cocaine seeking (rodents) and craving (humans) [86].”
BackgroundThe Effect of N-Acetylcysteine in the Nucleus Accumbens on Neurotransmission and Relapse to Cocaine
Kupchik, Y. M., Moussawi, K., Tang, X.-C., Wang, X., Kalivas, B. C., Kolokithas, R., Ogburn, K. B., & Kalivas, P. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.024 · Cited by 140 · cited 1×
“High concentrations of NAC in tissue slices lead to glutamate release from xCT that potentiates EPSCs in NA medium spiny cells [74].”
BackgroundSelf-citationManagement of Anaphylactoid Reactions to Intravenous N-Acetylcysteine
Bailey, B., & McGuigan, M. A. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70229-x · Cited by 134 · cited 1×
“Systemic allergic reactions to NAC have been observed, but only with intravenous administration [31, 32], and seizures have been reported at very high intravenous doses [33].”
BackgroundTrantham-Davidson, H., LaLumiere, R. T., Reissner, K. J., Kalivas, P. W., & Knackstedt, L. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1976-12.2012 · Cited by 134 · cited 1×
“It is possible that restoration of GLT1 after treatment with NAC will inhibit glutamate spillover into the extrasynaptic space via increased glutamate uptake [77], thus inhibiting activation of the primarily extrasynaptic NMDA receptor subunit, GluN2B [78].”
BackgroundSelf-citationBerglind, W. J., Whitfield, T. W., LaLumiere, R. T., Kalivas, P. W., & McGinty, J. F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5457-08.2009 · Cited by 131 · cited 2×
“tested to date elicit enduring reductions in GLT1) [44, 50– 52].”
BackgroundSelf-citationN-Acetylcysteine amide: a derivative to fulfill the promises of N-Acetylcysteine
Sunitha, K. R., Hemshekhar, M., Thushara, R. M., Santhosh, M. S., Yariswamy, M., Kemparaju, K., & Girish, K. S. (2013) · Free Radical Research · doi:10.3109/10715762.2013.781595 · Cited by 127 · cited 1×
“With this goal in mind, a recent study discussed the synthesis of an amide derivative NAC amide (NACA) [99].”
BackgroundReichel, C. M., Moussawi, K., Do, P. H., Kalivas, P. W., & See, R. E. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179317 · Cited by 124 · cited 1×
“Systemic administration of NAC has been shown to robustly decrease reinstatement of cocaine, heroin, and nicotine seeking in preclinical models [44, 45, 63, 80–83].”
BackgroundSelf-citationGlial glutamate transporter expression patterns in brains from multiple mammalian species
Williams, S. M., Sullivan, R. K. P., Scott, H. L., Finkelstein, D. I., Colditz, P. B., Lingwood, B. E., Dodd, P. R., & Pow, D. V. (2005) · Glia · doi:10.1002/glia.20139 · Cited by 117 · cited 1×
“Indeed, GLT1 is strategically expressed near the synaptic cleft to minimize glutamate spillover into the extrasynaptic space [58].”
BackgroundEvidence-Based Pharmacological Treatment of Substance Use Disorders and Pathological Gambling
van den Brink, W. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205010003 · Cited by 116 · cited 1×
“Several first- and second-line pharmacotherapeutic options exist for substance-specific SUDs and pathological gambling, and are discussed at length in a recent review by van den Brink [10].”
BackgroundGlutamate Transmission and Addiction to Cocaine
KALIVAS, P. W., McFARLAND, K., BOWERS, S., SZUMLINSKI, K., XI, Z., & BAKER, D. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.009 · Cited by 116 · cited 1×
“Since presynaptic and non-synaptic glutamate release regulates synaptic plasticity in both primary cell cultures and in vivo [63, 64], the LTP-like changes may arise from the reinstatement-associated increase in glutamate release and overflow [44, 45, 65].”
BackgroundSelf-citationGass, J. T., Sinclair, C. M., Cleva, R. M., Widholm, J. J., & Olive, M. F. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00262.x · Cited by 112 · cited 1×
“This exploration would also be supported by the literature, as increased glutamate levels have been found in the NAcore during cue-induced alcohol seeking [87].”
BackgroundEffects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.
van Schooten, F., Nia, A. B., Nia, A. B., Flora, S. D., D’Agostini, F., Izzotti, A., Camoirano, A., Balm, A. J. M., Dallinga, J. W., Bast, A., et al. (2002) · PubMed · Cited by 111
N‐Acetylcysteine (NAC) in Young Marijuana Users: An Open‐Label Pilot Study
Gray, K. M., Watson, N. L., Carpenter, M. J., & LaRowe, S. D. (2010) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00027.x · Cited by 109 · cited 1×
“Another openlabel investigation of NAC was conducted with cannabisdependent young adults (N = 24; aged 18–21 years) [90] over a 4-week treatment period with a dose of 2,400 mg/ day (1,200 mg twice daily).”
BackgroundSelf-citationPharmacotherapy for Cannabis Dependence: How Close Are We?
Vandrey, R., & Haney, M. (2009) · CNS Drugs · doi:10.2165/00023210-200923070-00001 · Cited by 108 · cited 1×
“and few positive controlled clinical trials exist to guide clinical practice [17, 18].”
Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons
Dringen, R., Gutterer, J. M., Gros, C., & Hirrlinger, J. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10042 · Cited by 104 · cited 1×
“NAC is a cysteine prodrug with antioxidant properties via activation of the Xc- system [72, 73].”
BackgroundN-acetylcysteine attenuates alcohol-induced oxidative stress in the rat
Özaras, R., Tahan, V., Aydın, S., Uzun, H., Kaya, S., & Şentürk, H. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i1.125 · Cited by 95 · cited 3×
“Finally, NAC has been shown to reduce alcohol-induced oxidative stress in rats [39, 40], and therefore may be of interest in the examination of NAC in the treatment of alcohol abuse and dependence.”
BackgroundGrant, J. E., Odlaug, B. L., & Kim, S. W. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.06.018 · Cited by 94 · cited 2×
“Another pilot RCT recruited non-treatment seeking methamphetamine-dependent adults (N = 31) to test the efficacy of NAC ? naltrexone versis placebo on methamphetamine craving and use [94].”
BackgroundRamirez-Niño, A. M., D’Souza, M. S., & Markou, A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2837-3 · Cited by 94 · cited 1×
“Acute administration of NAC has been shown to be effective at decreasing nicotine self-administration and nicotine seeking that is prompted by a previously paired cue [83].”
BackgroundSchmaal, L., Berk, L., Hulstijn, K. P., Cousijn, J., Wiers, R. W., & van den Brink, W. (2011) · European Addiction Research · doi:10.1159/000327682 · Cited by 93 · cited 1×
“Finally, an outpatient, laboratory-based, placebo-controlled study recruited nicotine-dependent young adults (N = 22) [92].”
Shen, H., Gipson, C. D., Huits, M., & Kalivas, P. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.318 · Cited by 84 · cited 1×
“This sequence of events leads to a rapid, transient increase in synaptic plasticity rendering increased relapse vulnerability [55– 57].”
BackgroundSelf-citationRole of mGluR5 neurotransmission in reinstated cocaine‐seeking
Wang, X., Moussawi, K., Knackstedt, L., Shen, H., & Kalivas, P. W. (2013) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00432.x · Cited by 83 · cited 1×
“The excessive release of extracellular glutamate during reinstated drug seeking arises from the decrease in GLT1 and stimulates extrasynaptic N-methyl-D-aspartate (NMDA) receptors and metabotropic glutamate receptor 5 [43, 54].”
BackgroundSelf-citationGlutamate Transporter 1: Target for the Treatment of Alcohol Dependence
Rao, S., & Sari, Y. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803530511 · Cited by 79 · cited 1×
“evidence indicates that chronic exposure to addictive drugs decreases the expression of the excitatory amino-acid transporter-2 (EAAT2), also known as glial glutamate transporter-1 (GLT1), in the NA [44, 47–49].”
BackgroundAn update of N-acetylcysteine treatment for acute acetaminophen toxicity in children
Marzullo, L. R. (2005) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000152622.05168.9e · Cited by 72 · cited 1×
“NAC may be appropriate among varying age groups since it has been used safely for several decades in adults and children, often at doses greatly exceeding those typically used in research studies [34, 35].”
BackgroundPharmacological Treatment of Cannabis Dependence
M. Weinstein, A., & A. Gorelick, D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150846 · Cited by 70 · cited 1×
“and few positive controlled clinical trials exist to guide clinical practice [17, 18].”
BackgroundBailey, B., Blais, R., & Letarte, A. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.05.014 · Cited by 65 · cited 1×
“Systemic allergic reactions to NAC have been observed, but only with intravenous administration [31, 32], and seizures have been reported at very high intravenous doses [33].”
BackgroundPalmatier, M. I., Liu, X., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301623 · Cited by 63 · cited 1×
“The excessive release of extracellular glutamate during reinstated drug seeking arises from the decrease in GLT1 and stimulates extrasynaptic N-methyl-D-aspartate (NMDA) receptors and metabotropic glutamate receptor 5 [43, 54].”
BackgroundMurray, J. E., Everitt, B. J., & Belin, D. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00330.x · Cited by 62
Agonist Replacement for Stimulant Dependence: A Review of Clinical Research
Stoops, W., & Rush, C. (2013) · Current Pharmaceutical Design · doi:10.2174/138161281940131209142843 · Cited by 60 · cited 1×
“Finally, there are currently no US FDA-approved medications for cocaine and other stimulant dependence, although some have suggested that agonist replacement approaches may be a fruitful avenue to explore [19].”
BackgroundSeiva, F. R. F., Amauchi, J. F., Rocha, K. K. R., Ebaid, G. M. X., Souza, G. A., Fernandes, A. A. H., Cataneo, A. C., & Novelli, E. L. B. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.09.028 · Cited by 55 · cited 3×
“Finally, NAC has been shown to reduce alcohol-induced oxidative stress in rats [39, 40], and therefore may be of interest in the examination of NAC in the treatment of alcohol abuse and dependence.”
BackgroundThe Story of Glutamate in Drug Addiction and ofN-Acetylcysteine as a Potential Pharmacotherapy
Brown, R. M., Kupchik, Y. M., & Kalivas, P. W. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.2207 · Cited by 48
Self-citationEffects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats
Seiva, F. R. F., Amauchi, J. F., Rocha, K. K. R., de Souza, G. A., Ebaid, G. M. X., Burneiko, R. M., & Novelli, E. L. B. (2009) · Alcohol · doi:10.1016/j.alcohol.2008.12.003 · Cited by 45 · cited 1×
“Additionally, the effects of NAC on alcohol withdrawal and other alcohol-induced aversive effects in a rodent model have been explored [39, 40, 100], with promising results.”
BackgroundIs Cocaine Desire Reduced by <char aid="99897189" id="ital">N</char>-Acetylcysteine?
LaRowe, S. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.7.1115 · Cited by 41
Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial
Roten, A. T., Baker, N. L., & Gray, K. M. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.11.003 · Cited by 35 · cited 1×
“Interestingly, although NAC was efficacious in promoting cannabis abstinence, a secondary analysis from this data set found no differential reductions in cannabis craving between the NAC and placebo groups, although craving did decrease over the course of the trial, regardless of treatment group [96].”
Self-citationSpine Modifications Associated with Long-Term Potentiation
Yang, Y., & Zhou, Q. (2009) · The Neuroscientist · doi:10.1177/1073858409340800 · Cited by 33 · cited 1×
“The LTP-like changes observed in these studies were quantified as increases in dendritic spine head diameter (dh) and in the ratio of a-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid (AMPA) receptor to NMDA-mediated excitatory postsynaptic currents (EPSCs; AMPA/NMDA) [60–62].”
MethodRheological assessment of mucolytic agents on sputum of chronic bronchitics
Dippy, J. E., & Davis, S. S. (1969) · Thorax · doi:10.1136/thx.24.6.707 · Cited by 27 · cited 1×
“Local irritation has also been reported when NAC is administered as a mucolytic [30].”
Background
Cited by
Everitt, B. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12644 · Cited by 318
“Having first been shown to prevent relapse in both cue and drug extinction–reinstatement procedures (Zhou & Kalivas, 2008; McClure et al., 2014),”
BackgroundInfluentialTreatment of Cannabis Use Disorder: Current Science and Future Outlook
Sherman, B. J., & McRae‐Clark, A. L. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1747 · Cited by 208
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray, K. M., Sonne, S. C., McClure, E. A., Ghitza, U. E., Matthews, A. G., McRae-Clark, A. L., Carroll, K. M., Potter, J. S., Wiest, K., Mooney, L. J., et al. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.04.020 · Cited by 157
“2.3 General Procedures Details of study design have been described previously (McClure et al., 2014).”
BackgroundMethodSelf-citationPharmacological Treatment of Youth Substance Use Disorders
Squeglia, L. M., Fadus, M. C., McClure, E. A., Tomko, R. L., & Gray, K. M. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0009 · Cited by 79
Self-citationCullen, K. R., Schreiner, M. W., Klimes-Dougan, B., Eberly, L. E., LaRiviere, L. L., Lim, K. O., Camchong, J., & Mueller, B. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109778 · Cited by 34
Metadata
- Authors
- McClure, E. A., Gipson, C. D., Malcolm, R. J., Kalivas, P. W., & Gray, K. M.
- Venue
- CNS Drugs
- Published
- 2014-01-18
- Volume
- 28
- Issue
- 2
- Pages
- 95-106
- ISSN
- 1172-7047 (ISSN-L)
- 1179-1934
- OpenAlex
- W1971398808
- Cited by
- 193
- References
- 108
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.